Gabriela Der Agopian Guardia retweeted
We're happy to share that our article on HER2 isoforms was chosen as the cover story of the month in Genome Research! Check out the illustration, created by a breast cancer survivor treated in our institution, here: genome.cshlp.org/content/35/…
Full story here: genome.cshlp.org/content/ear…
Gabriela Der Agopian Guardia retweeted
Honored to share that the study we contributed to has won the 16th Octávio Frias de Oliveira Award in the Oncology Research category in Brazil! It’s a special joy to receive this award for the second time (first in 2015). #BrazilianScience #Oncology
Gabriela Der Agopian Guardia retweeted
New paper alert! 🚨 Our team just published a study on HER2 isoform diversity in breast cancer and the role of alternative splicing in therapy resistance. Read more: genome.cshlp.org/content/ear…. Here are 5 key insights:
Gabriela Der Agopian Guardia retweeted
Our latest article, now available on MedRXiv, presents new findings on: "Tumor Spectrum and Temporal Cancer Trends in adult carriers of Li-Fraumeni syndrome: Implications for Personalized Screening Strategies in TP53 R337H carriers". medrxiv.org/content/10.1101/…
Gabriela Der Agopian Guardia retweeted
Our latest pre-print introduces Sandy, a pipeline designed to generate synthetic reads that emulate NGS sequencing (Illumina, Nanopore, and PacBio). Sandy is user-friendly, efficient, and captures a broad spectrum of features characteristic of real NGS.
biorxiv.org/content/10.1101/…
Gabriela Der Agopian Guardia retweeted
Our newest work (uploaded on BioRxiv) shows that mRNAs retrotransposition is a key mechanism for the generation of novel miRNAs in primates. Congrats @rafaelluizmercuri @hbconceicao @DerGuardia.
biorxiv.org/cgi/content/shor… #Genomics #Bioinformatics
Gabriela Der Agopian Guardia retweeted
So glad to see our collaboration (@DerGuardia @pafgalante) with @LOFPenalva published in Neuro-Oncology.
ELF4 is a critical component of a miRNA-transcription factor network and is a bridge regulator of glioblastoma receptor signaling and lipid dynamics academic.oup.com/neuro-oncol…
Gabriela Der Agopian Guardia retweeted
Pleased to see our collaboration with
Birbrair's lab (UFMG) published!
doi.org/10.1186/s40478-021-0…
Congrats to @DerGuardia students in Galante's lab.
Gabriela Der Agopian Guardia retweeted
Congrats to
@flprcsantos, @DerGuardia and @Filipe_FSantos
on our newest paper on NAR Cancer!
Reboot: a straightforward approach to identify genes and splicing isoforms associated with cancer patient prognosis academic.oup.com/narcancer/a…
Gabriela Der Agopian Guardia retweeted
Congrats to Thiago, Leonel and @nanda_orr on our newest paper on Bioinformatics!
sideRETRO: a pipeline for identifying somatic and polymorphic insertions of processed pseudogenes or retrocopies academic.oup.com/bioinformat…
Gabriela Der Agopian Guardia retweeted
Reboot: a straightforward approach to identify genes and splicing isoforms associated with cancer patient prognosis biorxiv.org/cgi/content/shor… #bioRxiv
Gabriela Der Agopian Guardia retweeted
Pleased to see our collaboration with Penalva's lab published! Congrats to @DerGuardia and Fabi Meliso in our lab.
Study finding that the RNA binding protein SERBP1 is oncogenic in glioblastoma, from @RawTaterTot13, @pafgalante, Tiziani, Penalva et al. It is overexpressed in GBM relative to brain. Knock down reduces proliferation, and affects metabolism genomebiology.biomedcentral.…





